Article Details
Retrieved on: 2023-10-24 21:02:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The drug, which is designed to treat respiratory syncytial virus (RSV), is technically a monoclonal antibody, not a vaccine, but the end result ...
Article found on: themessenger.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here